Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome
Richard Childs(National Heart Lung and Blood Institute), Georg Aue(National Institutes of Health), Enkhtsetseg Purev(University of Colorado Denver), Ritesh R. Kotecha(Memorial Sloan Kettering Cancer Center), Brian Wells(National Institutes of Health), Xin Tian(National Institutes of Health), Joseph Clara(National Institutes of Health), Mattias Carlsten(Karolinska University Hospital), Willy A. Flegel(National Institutes of Health Clinical Center), Tatyana Worthy(National Institutes of Health), Phuong Vo(University of Washington Medical Center), Jennifer Wilder(Science Applications International Corporation (United States)), Hanh Khuu(Microbiology Society), Robert Reger(National Institutes of Health), Sharon Adams(National Institutes of Health Clinical Center), Lisa Cook(National Institutes of Health), David F. Stroncek(Yale University), Nancy L. Geller(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 12
Related Papers
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331
RHD gene deletion occurred in the Rhesus box
|Blood|2000|319
RHD positive haplotypes in D negative Europeans
|BMC Genetics|2001|310